The purpose of this study was to determine the effects of modifying stride length (SL) on knee adduction and flexion moments, two markers of knee loading associated with medial-compartment knee osteoarthritis (OA) progression. This study also tested if SL modifications, in addition to foot progression angle (FP) and step width (SW) modifications, provide solutions in more subjects for reducing knee adduction moment (KAM) without increasing knee flexion moment (KFM), potentially protecting the joint. Fourteen healthy subjects (six female) were enrolled in this preliminary study. Walking trials were collected first without instructions, and then following foot placement instructions for 50 combinations of SL, FP, and SW modifications. Repeated measures analysis of variance was used to detect group-average effects of footprint modifications on maximum KAM and KFM and on KAM impulse. Subject-specific dose–responses between footprint modifications and kinetics changes were modeled with linear regressions, and the models were used to identify modification solutions, per subject, for various kinetics change conditions. Shorter SL significantly decreased the three kinetics measures (p < 0.01). Potential solutions for 10% reductions in maximum KAM and KAM impulse without increasing maximum KFM were identified for five subjects with FP and SW modifications. A significantly higher proportion of subjects had solutions when adding SL modifications (11 subjects, p = 0.04). In conclusion, SL is a valuable parameter to modify, especially in combination with FP and SW modifications, to reduce markers of medial knee loading. Future work is needed to extend these findings to osteoarthritic knees.
Using insoles to modify walking biomechanics is of keen interest for the treatment of medial-compartment knee osteoarthritis. So far, insole interventions have focused on reducing the peak of the knee adduction moment (pKAM) and have led to inconsistent clinical outcomes. This study aimed to evaluate the changes in other gait variables related to knee osteoarthritis when patients walk with different insoles to provide insights into the necessity to enlarge the biomechanical analyses to other variables. Walking trials were recorded for 10 patients in four insole conditions. Changes among conditions were computed for six gait variables, including the pKAM. The associations between the changes in pKAM and the changes in the other variables were also assessed individually. Walking with different insoles had noticeable effects on the six gait variables, with high heterogeneity among patients. For all variables, at least 36.67% of the changes were of medium-to-large effect size. The associations with the changes in pKAM varied among variables and patients. In conclusion, this study showed that varying the insole could globally influence ambulatory biomechanics and that limiting measurement to the pKAM could lead to an important loss of information. Beyond the consideration of additional gait variables, this study also encourages personalized interventions to address inter-patient variability.
13 June 2023 in Frontiers in Bioengineering and Biotechnology
Objective: To characterize ambulatory knee moments with respect to medial knee osteoarthritis (OA) severity comprehensively and to assess the possibility of developing a severity index combining knee moment parameters.Methods: Nine parameters (peak amplitudes) commonly used to quantify three-dimensional knee moments during walking were analyzed for 98 individuals (58.7 ± 9.2 years old, 1.69 ± 0.09 m, 76.9 ± 14.5 kg, 56% female), corresponding to three medial knee osteoarthritis severity groups: non-osteoarthritis (n = 22), mild osteoarthritis (n = 38) and severe osteoarthritis (n = 38). Multinomial logistic regression was used to create a severity index. Comparison and regression analyses were performed with respect to disease severity.Results: Six of the nine moment parameters differed statistically significantly among severity groups (p ≤ 0.039) and five reported statistically significant correlation with disease severity (0.23 ≤ |r| ≤ 0.59). The proposed severity index was highly reliable (ICC = 0.96) and statistically significantly different between the three groups (p < 0.001) as well as correlated with disease severity (r = 0.70).Conclusion: While medial knee osteoarthritis research has mostly focused on a few knee moment parameters, this study showed that other parameters differ with disease severity. In particular, it shed light on three parameters frequently disregarded in prior works. Another important finding is the possibility of combining the parameters into a severity index, which opens promising perspectives based on a single figure assessing the knee moments in their entirety. Although the proposed index was shown to be reliable and associated with disease severity, further research will be necessary particularly to assess its validity.
13 December 2025 in Journal of Orthopaedic Research
Progression of medial knee osteoarthritis (OA) has been associated with walking biomechanics, specifically with the knee adduction (KAM) and flexion (KFM) moments. Lower medial stiffness shoes (LMSS), that are shoes with the sole made of softer material medially than laterally, were proposed for disease management through KAM reductions. This study primarily tested the hypothesis that larger pKAM reductions can be achieved with stiffness ratios selected individually than with the smallest ratios of the LMSS. Secondarily, the proportions of individuals reducing the KAM or reducing the KAM without increasing the KFM were compared between the individualized and smallest ratios conditions. The two LMSS conditions were also compared with lateral wedge insoles. Walking biomechanics were recorded for 15 OA patients (8 males; 62.3 ± 9.6 years old) and 14 asymptomatic individuals (5 males; 53.6 ± 3.6 years old) wearing LMSS with various stiffness ratios and wedges. Larger decreases in KAM were obtained with individualized stiffness ratios (14.0%–16.4%) than with the two other interventions (6.7%–12.5%) ( p < 0.001). The percentage of participants reducing the KAM without increasing the KFM was larger with individualized ratios compared to the smallest ratios in the OA group (14 vs. 6; p = 0.001) and compared to wedges in the asymptomatic group (13 vs. 6; p = 0.015). This exploratory study showed the potential of individualizing the stiffness ratios, particularly in terms of KAM reduction amplitude, percentage of individuals achieving specific modifications, and possibility to aim for more complex kinetic changes. Further work is necessary to assess the effect of individualized stiffness ratios on clinical outcomes.
12 December 2025 in Journal of Autism and Developmental Disorders
Purpose: Motor impairments are pervasive in Autism Spectrum Disorder (ASD), with atypical gait patterns often observed but understudied in early development. The aim of this pilot study was to analyze spatiotemporal gait parameters and variability in toddlers with ASD compared to typically developing (TD) peers. Methods: The study included 12 ASD and 9 TD male toddlers, aged 18–30 months, walking independently. We extracted spatiotemporal gait parameters from laboratory recordings of walking. Gait variability was assessed via coefficients of variation for each parameter. Group differences were tested and exploratory correlations between gait parameters and motor skills were assessed. Results: Results indicated increased gait variability in the ASD group across parameters, suggesting less consistent motor control. Significant differences in variability were observed in stride length, step length, stance time, and stride time. Conclusion: This pilot study confirms that an objective assessment of gait is feasible in toddlers with ASD. Future research is needed to replicate the results in a larger sample, to explore underlying neurological mechanisms, as well as the impact of atypical gait maturation on other developmental domains. Early identification of atypical gait patterns could aid in designing interventions targeting motor development, potentially improving broader developmental outcomes in ASD.